Consistently, our results show that high PD-L1 expression on CD14- CD16+ monocytes correlates with reduced TB progression risk, suggesting that PD-L1 may exert protective effects during TB infection through regulation of innate immune activation, rather than solely through immune suppression. The gene discussed is CD14; the disease is tuberculosis.